|
|
||||||||
Experimental Studies |
1 From the Depts of Radiology (H.J.C., D.F.K., W.F.M., J.K.M., J.E.D., M.E.J.), Neurological Surgery (S.B.H., G.A.H.), and Pathology (M.B.L.), University of Virginia Health Sciences Center, Charlottesville, and ReGen, Franklin Lakes, NJ (H.B.L., S.T.L.). From the 1997 RSNA scientific assembly. Received May 14, 1998; revision requested July 13; revision received May 11, 1999; accepted June 28. Supported in part by a 1995 (2) Seed Grant from the RSNA R&E Foundation. D.F.K. supported by the RSNA R&E Foundation as a 1997 RSNA scholar. Address reprint requests to H.J.C., Dept of Radiology, Emory University Hospital, 1364 Clifton Rd NE, Atlanta, GA 30322 (e-mail:harry_cloft@emory.org).
PURPOSE: To study the biocompatibility of a bovine type I collagen preparation as a material for small-vessel stent-grafts in rabbits.
MATERIALS AND METHODS: A composite nitinol-collagen endovascular stent-graft with a 4-mm inner diameter was deployed in the abdominal aorta in nine rabbits. Angiography was performed, and the rabbits were sacrificed at 1, 2, and 7 days and at 1 and 3 months. The portion of the aorta containing the stent-graft was excised and was histologically evaluated.
RESULTS: All stent-grafts were patent at all time points. On days 1, 2, and 7 after implantation, scattered red and white blood cells adhered to the stent-graft. At 1 month, the stent-graft was endothelialized and was infiltrated with fibroblasts that deposited collagen within the interstices of the implanted collagen material. At 3 months, there was additional collagen deposition within the interstices of the stent-graft that did not narrow the lumen of the stent-grafts.
CONCLUSION: Type I collagen as a intravascular stent-graft material is biocompatible for at least 3 months in rabbits. It is rapidly endothelialized and does not cause reactive stenosis. As a versatile and biocompatible polymer, collagen is potentially useful in the construction of endovascular stent-grafts for use in human arteries.
Index terms: Animals Aorta, grafts and prostheses, 981.1268 Aortography, 981.121 Interventional procedures, experimental studies, 981.1268 Stents and prostheses, 981.1268
This article has been cited by other articles:
![]() |
N. Nagai, K. Mori, and M. Munekata Biological Properties of Crosslinked Salmon Collagen Fibrillar Gel as a Scaffold for Human Umbilical Vein Endothelial Cells J Biomater Appl, November 1, 2008; 23(3): 275 - 287. [Abstract] [PDF] |
||||
![]() |
D. R. Whittaker and M. F. Fillinger The Engineering of Endovascular Stent Technology: A Review Vascular and Endovascular Surgery, March 1, 2006; 40(2): 85 - 94. [Abstract] [PDF] |
||||
![]() |
J. F.W. Keuren, S. J.H. Wielders, A. Driessen, M. Verhoeven, M. Hendriks, and T. Lindhout Covalently-Bound Heparin Makes Collagen Thromboresistant Arterioscler. Thromb. Vasc. Biol., March 1, 2004; 24(3): 613 - 617. [Abstract] [Full Text] |
||||